NuSirt Sciences, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2007-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.nusirt.com
Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity
- Conditions
- Obesity
- Interventions
- First Posted Date
- 2017-12-06
- Last Posted Date
- 2019-08-21
- Lead Sponsor
- NuSirt Biopharma
- Target Recruit Count
- 267
- Registration Number
- NCT03364335
- Locations
- 🇺🇸
AMR, Las Vegas, Nevada, United States
🇺🇸Catalina Research Institute, Montclair, California, United States
🇺🇸Northern California Research, Sacramento, California, United States
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
- Conditions
- NAFLD
- Interventions
- Drug: PlaceboDrug: Leu-Met-Sil 0.5Drug: Leu-Met-Sil 1.0
- First Posted Date
- 2015-09-11
- Last Posted Date
- 2018-05-02
- Lead Sponsor
- NuSirt Biopharma
- Target Recruit Count
- 91
- Registration Number
- NCT02546609
- Locations
- 🇺🇸
Catalina Research Institute, Chino, California, United States
🇺🇸University of California San Diego, San Diego, California, United States
🇺🇸Rocky Mountain Research, Wheat Ridge, Colorado, United States
An Extension Protocol to Evaluate Dose Comparisons of Leucine-Metformin Combinations in Type 2 Diabetic Patients
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2015-05-06
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- NuSirt Biopharma
- Target Recruit Count
- 50
- Registration Number
- NCT02435277
- Locations
- 🇺🇸
Catalina Research Institute, Chino, California, United States
🇺🇸Palm Beach Research, Palm Beach, Florida, United States
🇺🇸Meridien Research, Tampa, Florida, United States
Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2014-05-30
- Last Posted Date
- 2018-02-27
- Lead Sponsor
- NuSirt Biopharma
- Target Recruit Count
- 96
- Registration Number
- NCT02151461
- Locations
- 🇺🇸
Catalina Research Institute, Chino, California, United States
🇺🇸Palm Beach Research, Palm Beach, Florida, United States
🇺🇸Meridien Research, Tampa, Florida, United States